Nurix Therapeutics Inc [NRIX]
Pivotdata
Pivotstatistikk
| Måltall | Snitt | Median | Std.avvik |
|---|---|---|---|
| Gevinst % | 18.21% | 18.21% | 2.36% |
| Tap % | -17.57% | -17.57% | 0.00% |
| Varighet | 10.0d | 10d | 3.0d |
| Totalt antall pivoter | 4 |
| Gevinst-/tapsbein | 3 (2 Gevinst / 1 Tap) |
| Siste pivot | Top @ $17.55 den 2026-06-18 |
| Endring siden siste pivot | $0.00 (0.00%) |
Neste pivotprognose Siste: $0.00
| Forventet neste type | Bottom |
| Forventet pris (snitt) | $14.47 |
| Forventet pris (median) | $14.47 |
| Forventet prisintervall (~68%) | $14.47 - $14.47 |
| Endring til snittmål | $14.47 (N/A) |
| Forventet dato (snitt) | 2026-06-28 |
| Forventet datointervall (~68%) | 2026-06-25 - 2026-07-01 |
| Grunnlag | Based on 1 historical losses (Avg: -17.57%, Median: -17.57%, StdDev of Abs: 0.00%) and duration (Avg: 10.0 days, StdDev: 3.0 days) |
| Merk | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Nurix Therapeutics Inc rose moderately, up 2.51% on Thursday.
Nurix Therapeutics Inc (NRIX) stock price delivered a strong performance on Thursday after the stock rose $0.430 (2.51%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise.(The stock has risen 3 days straight. This extended rally increases the chances of a price pullback soon) A total of 4.25M stocks were traded yesterday, valued at $74.60M, 1.74M shares more than the previous day (2 514 280 shares traded). This is near the average volume for the stock at 4.79M shares traded per day.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Strong Bullish Consensus: A powerful wave of positive momentum is evident across all timeframes. Technical indicators are decisively bullish in the short-term (17/30, net +53.3%), medium-term (17/30, net +53.3%), and long-term (17/30, net +53.3%), signaling a robust and sustained uptrend.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is trading above the closest support level at $17.00. approximately $0.550 (3.13%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s117 -
Nurix Therapeutics Inc Evaluation
- Kort score: 4.90
- Medium score: 5.88
- Lang score: 5.56